Bayer expects €11bn group sales in Asia by 2015 but wants premium drug pricing in India
This article was originally published in Scrip
Executive Summary
The Bayer group expects overall sales in Asia to exceed €11 billion by 2015, propelled by an expansion in the group's production, distribution and R&D activities the region. These plans would be backed by spending of about €1.8 billion by 2015 and a 27% increase in Bayer's Asian workforce to about 30,000 by then.